The accuracy of self-reported blood pressure in the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial: Implications for pragmatic trials

PDF0 bytes

Date Published:

Nov 14

Abstract:

Self-report of health conditions and behaviors is one potential strategy to increase the pace of enrollment into pragmatic clinical trials. In this study, we assessed the accuracy of self-reported poorly controlled hypertension among adults in the community who were screened for participation in the MedISAFE-BP trial. Of individuals who self-reported poorly controlled hypertension using the online trial enrollment platform, 64% had a systolic blood pressure less than 140 mm Hg when measured at home. Although we identified several characteristics associated with accurate self-report including older age (odds ratio [OR] 1.02 per year, 95% CI 1.01-1.03), diabetes (OR 1.59, 95% CI 1.17-2.14), and low health activation (OR 1.56 95% CI 1.17-2.07), we were unable to identify patients for whom self-reported hypertension would be a reliable method for their inclusion in a pragmatic trial.

Notes:

1097-6744Haff, NancyLauffenburger, Julie CMorawski, KyleGhazinouri, RoyaNoor, NudratKumar, ShefaliJuusola, JessieChoudhry, Niteesh KLetterUnited StatesAm Heart J. 2019 Nov 14;220:68-72. doi: 10.1016/j.ahj.2019.10.018.

Last updated on 02/05/2020